Tech Company Financing Transactions

SutroVax Funding Round

On 3/22/2017, SutroVax raised $64 million in Series B funding from Frazier Healthcare Partners, Pivotal bioVenture Partners and Abingworth.

Transaction Overview

Company Name
SutroVax
Announced On
3/22/2017
Transaction Type
Venture Equity
Amount
$64,000,000
Round
Series B
Investors

Frazier Healthcare Partners (Lead Investor) (Patrick Heron)

Pivotal bioVenture Partners (Lead Investor) (Tracy Saxton)

Abingworth (Kurt Emster)

CTI Life Sciences Fund

Longitude Capital Management

Roche Venture Fund

Proceeds Purpose
SutroVax will use the proceeds from this financing to advance its lead pneumococcal conjugate vaccine (PCV), which prevents invasive pneumococcal disease caused by Streptococcus pneumoniae, and accelerate the Company's antigen discovery and early-stage development efforts in other disease areas.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
353 Hatch Dr.
Foster City, CA 94404
USA
Phone
(650) 837-0111
Website
www.sutrovax.com
Email Address
[email protected]
Overview
SutroVax is an independent vaccine platform and development company that was spun-out of Sutro Biopharma. The company will leverage Sutro's Xpress CF and Xpress CF+ platforms for cell-free protein synthesis and site-specific conjugation to develop novel vaccines for an array of disease targets.
Profile
SutroVax LinkedIn Company Profile
Social Media
SutroVax Company Twitter Account
Company News
SutroVax News
Facebook
SutroVax on Facebook
YouTube
SutroVax on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Grant Pickering
  Grant Pickering LinkedIn Profile  Grant Pickering Twitter Account  Grant Pickering News  Grant Pickering on Facebook
Chief Medical Officer
Alan Kimura
  Alan Kimura LinkedIn Profile  Alan Kimura Twitter Account  Alan Kimura News  Alan Kimura on Facebook
Chief Operating Officer
James Wassil
  James Wassil LinkedIn Profile  James Wassil Twitter Account  James Wassil News  James Wassil on Facebook
VP - General Counsel
Jane Mitchell
  Jane Mitchell LinkedIn Profile  Jane Mitchell Twitter Account  Jane Mitchell News  Jane Mitchell on Facebook
VP - Manufacturing
Paul Sauer
  Paul Sauer LinkedIn Profile  Paul Sauer Twitter Account  Paul Sauer News  Paul Sauer on Facebook
VP - R & D
Jeff Fairman
  Jeff Fairman LinkedIn Profile  Jeff Fairman Twitter Account  Jeff Fairman News  Jeff Fairman on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/22/2017: DeepScale venture capital transaction
Next: 3/22/2017: Innovu venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.